Evidence map›Paper›PMID 36839711›Full record

ArticlePharmaceutics2023

Voriconazole Cyclodextrin Based Polymeric Nanobeads for Enhanced Solubility and Activity: In Vitro/In Vivo and Molecular Simulation Approach.

Mudassir Farooq, Faisal Usman, Mahrukh Naseem, Hanan Y Aati, Hassan Ahmad, Sirikhwan Manee, Ruqaiya Khalil, Kashif Ur Rehman Khan, Muhammad Imran Qureshi, Muhammad Umair

Abstract read
In one paragraph

Article in Pharmaceutics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Mudassir FarooqDepartment of Pharmaceutics, Faculty of Pharmacy, Bahauddin Zakariya University, Multan 60800, Pakistan.ORCID 0000-0002-0586-3476
Faisal UsmanDepartment of Pharmaceutics, Faculty of Pharmacy, Bahauddin Zakariya University, Multan 60800, Pakistan.ORCID 0000-0002-8998-9454
Mahrukh NaseemDepartment of Zoology, University of Balochistan, Quetta 08770, Pakistan.
Hanan Y AatiDepartment of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh 11495, Saudi Arabia.ORCID 0000-0003-1598-2273
Hassan AhmadFaculty of Pharmaceutical Sciences, University of Central Punjab, Lahore 54000, Pakistan.ORCID 0000-0001-5053-5968
Sirikhwan ManeeTraditional Thai Medicine Research and Innovation Center, Faculty of Traditional Thai Medicine, Prince of Songkla University, Songkhla 90110, Thailand.ORCID 0000-0003-2958-4284
Ruqaiya KhalilCentro De Investigaciones Biomédicas, University of Vigo, 36310 Vigo, Spain.
Kashif Ur Rehman KhanDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, The Islamia University of Bahawalpur, Bahawalpur 66000, Pakistan.ORCID 0000-0002-3581-5600
Muhammad Imran QureshiDepartment of Pharmaceutics, Faculty of Pharmacy, The Islamia University of Bahawalpur, Bahawalpur 66000, Pakistan.
Muhammad UmairCollege of Pharmacy, Shenzhen Technology University, Shenzhen 518060, China.ORCID 0000-0002-2035-686X

Funding

King Saud University RSP2022R504
6 · The paper itself

Abstract

Hydroxypropyl β-cyclodextrin (HPβCD) based polymeric nanobeads containing voriconazole (VRC) were fabricated by free radical polymerization using

Indexed as

free radical polymerizationfungal infectionhydroxy propyl β cyclodextrinnanobeadsvoriconazole

Identifiers

PMID36839711
PMCPMC9968121

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.